SCYNEXIS Stock (NASDAQ: SCYX) stock price, news, charts, stock research, profile.
Open | $1.800 |
Close | $1.770 |
Volume / Avg. | 173.113K / 206.052K |
Day Range | 1.700 - 1.900 |
52 Wk Range | 1.350 - 3.870 |
Market Cap | $62.714M |
P/E Ratio | 1.281 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 0 |
Short Interest | 3.41% |
Days to Cover | 4.15 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of SCYNEXIS (NASDAQ: SCYX) through any online brokerage.
Other companies in SCYNEXIS’s space includes: CalciMedica (NASDAQ:CALC), Jaguar Health (NASDAQ:JAGX), Ocuphire Pharma (NASDAQ:OCUP), Marinus Pharma (NASDAQ:MRNS) and Nutriband (NASDAQ:NTRB).
The latest price target for SCYNEXIS (NASDAQ: SCYX) was reported by Cantor Fitzgerald on Monday, April 1, 2024. The analyst firm set a price target for 0.00 expecting SCYX to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.
The stock price for SCYNEXIS (NASDAQ: SCYX) is $1.66 last updated April 30, 2024 at 5:09 PM EDT.
There are no upcoming dividends for SCYNEXIS.
SCYNEXIS’s Q1 earnings are confirmed for Friday, May 17, 2024.
There is no upcoming split for SCYNEXIS.
SCYNEXIS is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.